Ngā hua rapu kaituhi :: APM

1

Targeting Molecular Measurable Residual Disease and Low-Blast Relapse in AML With Venetoclax and Low-Dose Cytarabine: A Prospective Phase II Study (VALDAC) mā Ing Soo Tiong, Devendra Hiwase, Emad Uddin Abro, Ashish Bajel, Emma Palfreyman, Ashanka Beligaswatte, John Reynolds, Natasha S. Anstee, Tamia Nguyen, Sun Loo, Chong Chyn Chua, Michael Ashby, Kaitlyn Wiltshire, Shaun Fleming, Chun Yew Fong, Tse‐Chieh Teh, Piers Blombery, Richard Dillon, Adam Ivey, Andrew H. Wei

I whakaputaina 2024

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
2

Clinical impact of <i>NPM1</i>-mutant molecular persistence after chemotherapy for acute myeloid leukemia mā Ing Soo Tiong, Richard Dillon, Adam Ivey, James A. Kuzich, Nisha Thiagarajah, Kirsty Sharplin, Chung Hoow Kok, Aditya Tedjaseputra, James Rowland, Carolyn Grove, Emad Uddin Abro, Jake Shortt, Devendra Hiwase, Ashish Bajel, Nicola Potter, Matthew L Smith, Claire Hemmaway, Abin Thomas, Amanda Gilkes, Nigel H. Russell, Andrew H. Wei

I whakaputaina 2021

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
3

LAG3: a novel immune checkpoint expressed by multiple lymphocyte subsets in diffuse large B-cell lymphoma mā Colm Keane, Soi Cheng Law, Clare Gould, Simone Birch, Muhammed B. Sabdia, Lilia Merida de Long, Gayathri Thillaiyampalam, Emad Uddin Abro, Joshua W.D. Tobin, Xiaohong Tan, Zijun Y. Xu‐Monette, Ken H. Young, Grace Gifford, Sara Gabreilli, William Stevenson, Anthony J. Gill, Dipti Talaulikar, Sanjiv Jain, Annette Hernandez, Sarah-Jane Halliday, Robert Bird, Donna Cross, Mark Hertzberg, Maher K. Gandhi

I whakaputaina 2020

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i: